Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Benefit of interpregnancy HIV viral load suppression on subsequent maternal and infant outcomes.

Stewart RD, Wells CE, Roberts SW, Rogers VL, McElwee BS, McIntire DD, Sheffield JS.

Am J Obstet Gynecol. 2014 Sep;211(3):297.e1-6. doi: 10.1016/j.ajog.2014.04.020. Epub 2014 Apr 15.

PMID:
24746998
2.

Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.

Read JS, Cahn P, Losso M, Pinto J, Joao E, Duarte G, Cardoso E, Freimanis-Hance L, Stoszek SK; NISDI Perinatal Study Group.

Obstet Gynecol. 2007 Jun;109(6):1358-67.

PMID:
17540808
3.

Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.

French CE, Tookey PA, Cortina-Borja M, de Ruiter A, Townsend CL, Thorne C.

Antivir Ther. 2013;18(2):183-92. doi: 10.3851/IMP2327. Epub 2012 Aug 22.

PMID:
23475123
4.

[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].

Panel de expertos de GESIDA y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Spanish.

PMID:
21388714
5.

Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.

Bhargav H, Huilgol V, Metri K, Sundell IB, Tripathi S, Ramagouda N, Jadhav M, Raghuram N, Ramarao NH, Koka PS.

J Stem Cells. 2012;7(3):127-53. doi: jsc.2012.7.3.127.

PMID:
23619381
6.
7.

Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.

Palacios R, Senise J, Vaz M, Diaz R, Castelo A.

HIV Med. 2009 Mar;10(3):157-62. doi: 10.1111/j.1468-1293.2008.00665.x.

8.

[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Spanish.

PMID:
22633764
9.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
10.

Mother-to-child transmission of HIV: experience at a referral hospital in Saudi Arabia.

Edathodu J, Halim MM, Dahham MB, Alrajhi AA.

Ann Saudi Med. 2010 Jan-Feb;30(1):15-7. doi: 10.4103/0256-4947.59367.

11.

[Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].

Rodrigues A, Faucher P, Batallan A, Allal L, Legac S, Matheron S, Madelenat P.

Gynecol Obstet Fertil. 2006 Apr;34(4):304-11. Epub 2006 Mar 29. French.

PMID:
16574463
12.

Pregnancy outcomes in women with advanced HIV infection in Italy.

Baroncelli S, Tamburrini E, Ravizza M, Pinnetti C, Dalzero S, Scatà M, Crepaldi A, Liuzzi G, Molinari A, Vimercati A, Maccabruni A, Francisci D, Rubino E, Floridia M; Italian Group On Surveillance On Antiretroviral Treatment In Pregnancy.

AIDS Patient Care STDS. 2011 Nov;25(11):639-45. doi: 10.1089/apc.2011.0172. Epub 2011 Sep 23.

13.

Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.

Briand N, Jasseron C, Sibiude J, Azria E, Pollet J, Hammou Y, Warszawski J, Mandelbrot L.

Am J Obstet Gynecol. 2013 Oct;209(4):335.e1-335.e12. doi: 10.1016/j.ajog.2013.06.021. Epub 2013 Jun 18.

PMID:
23791563
14.

Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?

Briand N, Warszawski J, Mandelbrot L, Dollfus C, Pannier E, Cravello L, Nguyen R, Matheron I, Winer N, Tubiana R, Rouzioux C, Faye A, Blanche S; ANRS-EPF CO1-CO11 Study Group.

Clin Infect Dis. 2013 Sep;57(6):903-14. doi: 10.1093/cid/cit374. Epub 2013 May 31.

PMID:
23728147
15.

Achieving rapid reduction of HIV-1 viral load in HIV-positive pregnant women close to term - an obstetric/medical emergency: a review of three cases.

Adeyemo A, Wood C, Govind A.

Int J STD AIDS. 2013 Jul;24(7):591-2. doi: 10.1177/0956462413476275. Epub 2013 Jul 4.

PMID:
23970779
16.

Prevention of perinatal HIV transmission during pregnancy.

McGowan JP, Shah SS.

J Antimicrob Chemother. 2000 Nov;46(5):657-68. Review.

PMID:
11062184
17.

Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.

Aziz N, Sokoloff A, Kornak J, Leva NV, Mendiola ML, Levison J, Feakins C, Shannon M, Cohan D.

BJOG. 2013 Nov;120(12):1534-47. doi: 10.1111/1471-0528.12226. Epub 2013 Aug 7.

18.

Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery.

Giuliano M, Andreotti M, Liotta G, Jere H, Sagno JB, Maulidi M, Mancinelli S, Buonomo E, Scarcella P, Pirillo MF, Amici R, Ceffa S, Vella S, Palombi L, Marazzi MC.

PLoS One. 2013 Jul 19;8(7):e68950. doi: 10.1371/journal.pone.0068950. Print 2013.

19.

Maternal viral load, CD4 cell count and vertical transmission of HIV-1.

O'Shea S, Newell ML, Dunn DT, Garcia-Rodriguez MC, Bates I, Mullen J, Rostron T, Corbett K, Aiyer S, Butler K, Smith R, Banatvala JE.

J Med Virol. 1998 Feb;54(2):113-7.

PMID:
9496369
20.

When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?

Read PJ, Mandalia S, Khan P, Harrisson U, Naftalin C, Gilleece Y, Anderson J, Hawkins DA, Taylor GP, de Ruiter A; London HIV Perinatal Research Group.

AIDS. 2012 Jun 1;26(9):1095-103. doi: 10.1097/QAD.0b013e3283536a6c.

PMID:
22441248

Supplemental Content

Support Center